Rakovina Therapeutics' President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that its P
(Financial Post, 2025-11-18T09:02:21Z)